A Systematic Review of Mortality in Schizophrenia
Is the Differential Mortality Gap Worsening Over Time?
Sukanta Saha, MSc, MCN; David Chant, PhD; John McGrath, MD, PhD, FRANZCP
Arch Gen Psychiatry. 2007;64(10):1123-1131.
http://archpsyc.ama-assn.org/cgi/content/abstract/64/10/1123
It shows the standardised (all cause) mortality rates or ratio (SMR) for
people with schizophrenia in a few countries. The UK and the US come out
worst. This isn't a repeat of the IPSS result that showedbetter outcomes
in the developing world. Countries like Norway have a lower SMR than
neighbouring Finland and a considerably lower SMR than the UK. Norway
has an SMR of 1 which I think means people with a diagnosis of
schizophrenia in Norway live as long as people without a diagnosis of
schizophrenia.
I don't know why it happens. There might be some information in the rest
of the paper. To my untrained mind the significant difference between
the SMR in the UK and US is pretty significant.
In my mind I think working out what the other countries are doing and
applying it in the UK might improve the reduced life expectancy and
perhaps there are solutions so people wouldn't be prescribed clozapine.
The research on it's own makes a clear point that there's wrong with
mental health services in the UK that can be improved and the reduction
in life expectancy may, perhaps, be enough to knock up a health
economics argument to get whatever is working in those other countries
implemented here.
Why did I smash my laptop?
Anyway, there'll be a hiatus on this blog. I fancy renaming it
"Futility" or pissing in the ocean but I'd just be projecting what I am.
No comments:
Post a Comment